Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 7, 2005; 11(33): 5199-5202
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5199
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5199
Table 2 Tumor stage and serum RCAS1, CEA and CA19-9
| Stage | RCAS1 | CEA | CA19-9 | RCAS1+CEA | RCAS1+CA19-9 | CA19-9+CEA | ||||||
| Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | |
| 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
| 3 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 |
| 4A | 0 | 3 | 0 | 3 | 3 | 0 | 0 | 3 | 3 | 0 | 3 | 0 |
| 4B | 11 | 6 | 6 | 11 | 12 | 5 | 12 | 5 | 16 | 1 | 14 | 3 |
- Citation: Yamaguchi K, Enjoji M, Nakashima M, Nakamuta M, Watanabe T, Tanaka M. Novel serum tumor marker, RCAS1, in pancreatic diseases. World J Gastroenterol 2005; 11(33): 5199-5202
- URL: https://www.wjgnet.com/1007-9327/full/v11/i33/5199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i33.5199